NeoCura Ag
TM
NeoCura Ag is a frontier treatment regimen based on the artificial intelligence (AI) technology. Through high-throughput sample sequencing and AI algorithm prediction, it identifies the optimal neoantigen fragments that can be efficiently bound to and presented by patients' tumor cells, so as to trigger the immune response of the body to tumor-specific mutants, then synthesizes the corresponding coding mRNA neoantigen preparations for tumor treatment. Compared to traditional drugs, NeoCura Ag features stronger immunogenicity that can induce specific anti-tumor immune response in humans.Based on its R&D experience and technical superiority, NeoCura develops personalized neoantigens for different individuals and establishes public neoantigen libraries for multiple types of cancers through sequencing and data analysis of large number of clinical samples collected from tumor patients, which significantly reduces the cost of neoantigen drug therapy and shortens the preparation time. So far, NeoCura has cooperated with many hospitals to conduct relevant trials.